280 related articles for article (PubMed ID: 27872808)
1. Delineation of cortical pathology in multiple sclerosis using multi-surface magnetization transfer ratio imaging.
Rudko DA; Derakhshan M; Maranzano J; Nakamura K; Arnold DL; Narayanan S
Neuroimage Clin; 2016; 12():858-868. PubMed ID: 27872808
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal Fluid-In Gradient of Cortical and Deep Gray Matter Damage in Multiple Sclerosis.
Rubin M; Pagani E; Preziosa P; Meani A; Storelli L; Margoni M; Filippi M; Rocca MA
Neurol Neuroimmunol Neuroinflamm; 2024 Jul; 11(4):e200271. PubMed ID: 38896808
[TBL] [Abstract][Full Text] [Related]
3. Surface-based analysis reveals regions of reduced cortical magnetization transfer ratio in patients with multiple sclerosis: a proposed method for imaging subpial demyelination.
Derakhshan M; Caramanos Z; Narayanan S; Arnold DL; Louis Collins D
Hum Brain Mapp; 2014 Jul; 35(7):3402-13. PubMed ID: 24356893
[TBL] [Abstract][Full Text] [Related]
4. Investigation of outer cortical magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups.
Samson RS; Cardoso MJ; Muhlert N; Sethi V; Wheeler-Kingshott CA; Ron M; Ourselin S; Miller DH; Chard DT
Mult Scler; 2014 Sep; 20(10):1322-30. PubMed ID: 24552746
[TBL] [Abstract][Full Text] [Related]
5. Assessment of cortical damage in early multiple sclerosis with quantitative T2 relaxometry.
Gracien RM; Reitz SC; Hof SM; Fleischer V; Zimmermann H; Droby A; Steinmetz H; Zipp F; Deichmann R; Klein JC
NMR Biomed; 2016 Apr; 29(4):444-50. PubMed ID: 26820580
[TBL] [Abstract][Full Text] [Related]
6. Ultra-high field MTR and qR2* differentiates subpial cortical lesions from normal-appearing gray matter in multiple sclerosis.
Jonkman LE; Fleysher L; Steenwijk MD; Koeleman JA; de Snoo TP; Barkhof F; Inglese M; Geurts JJ
Mult Scler; 2016 Sep; 22(10):1306-14. PubMed ID: 26672996
[TBL] [Abstract][Full Text] [Related]
7. The association between intra- and juxta-cortical pathology and cognitive impairment in multiple sclerosis by quantitative T
Louapre C; Govindarajan ST; Giannì C; Madigan N; Nielsen AS; Sloane JA; Kinkel RP; Mainero C
Neuroimage Clin; 2016; 12():879-886. PubMed ID: 27872810
[TBL] [Abstract][Full Text] [Related]
8. Cortical neuronal densities and cerebral white matter demyelination in multiple sclerosis: a retrospective study.
Trapp BD; Vignos M; Dudman J; Chang A; Fisher E; Staugaitis SM; Battapady H; Mork S; Ontaneda D; Jones SE; Fox RJ; Chen J; Nakamura K; Rudick RA
Lancet Neurol; 2018 Oct; 17(10):870-884. PubMed ID: 30143361
[TBL] [Abstract][Full Text] [Related]
9. Increased cortical curvature reflects white matter atrophy in individual patients with early multiple sclerosis.
Deppe M; Marinell J; Krämer J; Duning T; Ruck T; Simon OJ; Zipp F; Wiendl H; Meuth SG
Neuroimage Clin; 2014; 6():475-87. PubMed ID: 25610761
[TBL] [Abstract][Full Text] [Related]
10. Cortical Damage and Disability in Multiple Sclerosis: Relation to Intracortical Inhibition and Facilitation.
Nantes JC; Zhong J; Holmes SA; Narayanan S; Lapierre Y; Koski L
Brain Stimul; 2016; 9(4):566-73. PubMed ID: 27053387
[TBL] [Abstract][Full Text] [Related]
11. Low degree of cortical pathology is associated with benign course of multiple sclerosis.
Calabrese M; Favaretto A; Poretto V; Romualdi C; Rinaldi F; Mattisi I; Morra A; Perini P; Gallo P
Mult Scler; 2013 Jun; 19(7):904-11. PubMed ID: 23069877
[TBL] [Abstract][Full Text] [Related]
12. Multi-layer analysis of quantitative 7 T magnetic resonance imaging in the cortex of multiple sclerosis patients reveals pathology associated with disability.
Lema Dopico A; Choi S; Hua J; Li X; Harrison DM
Mult Scler; 2021 Nov; 27(13):2040-2051. PubMed ID: 33596719
[TBL] [Abstract][Full Text] [Related]
13. Clinically feasible MTR is sensitive to cortical demyelination in MS.
Chen JT; Easley K; Schneider C; Nakamura K; Kidd GJ; Chang A; Staugaitis SM; Fox RJ; Fisher E; Arnold DL; Trapp BD
Neurology; 2013 Jan; 80(3):246-52. PubMed ID: 23269598
[TBL] [Abstract][Full Text] [Related]
14. A gradient in cortical pathology in multiple sclerosis by in vivo quantitative 7 T imaging.
Mainero C; Louapre C; Govindarajan ST; Giannì C; Nielsen AS; Cohen-Adad J; Sloane J; Kinkel RP
Brain; 2015 Apr; 138(Pt 4):932-45. PubMed ID: 25681411
[TBL] [Abstract][Full Text] [Related]
15. Magnetization transfer ratio measurement in multiple sclerosis normal-appearing brain tissue: limited differences with controls but relationships with clinical and MR measures of disease.
Vrenken H; Pouwels PJ; Ropele S; Knol DL; Geurts JJ; Polman CH; Barkhof F; Castelijns JA
Mult Scler; 2007 Jul; 13(6):708-16. PubMed ID: 17613597
[TBL] [Abstract][Full Text] [Related]
16. High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis.
Schmierer K; Parkes HG; So PW; An SF; Brandner S; Ordidge RJ; Yousry TA; Miller DH
Brain; 2010 Mar; 133(Pt 3):858-67. PubMed ID: 20123726
[TBL] [Abstract][Full Text] [Related]
17. Focal thinning of the cerebral cortex in multiple sclerosis.
Sailer M; Fischl B; Salat D; Tempelmann C; Schönfeld MA; Busa E; Bodammer N; Heinze HJ; Dale A
Brain; 2003 Aug; 126(Pt 8):1734-44. PubMed ID: 12805100
[TBL] [Abstract][Full Text] [Related]
18. Cortical atrophy patterns in multiple sclerosis are non-random and clinically relevant.
Steenwijk MD; Geurts JJ; Daams M; Tijms BM; Wink AM; Balk LJ; Tewarie PK; Uitdehaag BM; Barkhof F; Vrenken H; Pouwels PJ
Brain; 2016 Jan; 139(Pt 1):115-26. PubMed ID: 26637488
[TBL] [Abstract][Full Text] [Related]
19. Investigation of magnetization transfer ratio-derived pial and subpial abnormalities in the multiple sclerosis spinal cord.
Kearney H; Yiannakas MC; Samson RS; Wheeler-Kingshott CA; Ciccarelli O; Miller DH
Brain; 2014 Sep; 137(Pt 9):2456-68. PubMed ID: 24966048
[TBL] [Abstract][Full Text] [Related]
20. Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis.
De Stefano N; Battaglini M; Stromillo ML; Zipoli V; Bartolozzi ML; Guidi L; Siracusa G; Portaccio E; Giorgio A; Sorbi S; Federico A; Amato MP
Brain; 2006 Aug; 129(Pt 8):2008-16. PubMed ID: 16815879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
